Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue

Annals of Diagnostic Pathology

Volumn 15, Issue 1, 2011, Pages 37-45

  Reid Nicholson, Michelle D ^a   Motiwala, Nisrin ^a   Drury, Scott C ^a   Peiper, Stephen C ^a   Terris, Martha K ^a   Waller, Jennifer L ^a   Ramalingam, Preetha ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Renal cell carcinoma; Urovysion FISH

Indexed keywords

PARAFFIN;

ARTICLE; CARCINOMA; CHROMOSOME 7; CHROMOSOME ABERRATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; UROVYSION FLUORESCENCE IN SITU HYBRIDIZATION;

AGED; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; URINALYSIS;

EID: 78751490640     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2010.07.011     Document Type: Article

References (34)

1. Halling K.C. Vysis UroVysion for the detection of urothelial carcinoma Expert Rev Mol Diagn 3 4 2003 507 519
2. Skacel M., Fahmy M., and Brainard J.A. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology J Urol 169 6 2003 2101 2105
3. Sokolova I.A., Halling K.C., and Jenkins R.B. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine J Mol Diagn 2 3 2000 116 123
4. US Food and Drug Administration Center for Devices and Radiological Health New device approval: Urovysion bladder cancer: P030052. January 24. Vol Available at: http://www.fda.gov/cdrh/mda/docs/p030052.html
5. Halling K.C., King W., and Sokolova I.A. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 5 2000 1768 1775
6. Mitra A.P., Datar R.H., and Cote R.J. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification J Clin Oncol 24 35 2006 5552 5564
7. Bergman J., Reznichek R.C., and Rajfer J. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings BJU Int 101 1 2008 26 29
8. Sugano K., and Kakizoe T. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging Nat Clin Pract Urol 3 12 2006 642 652
9. Flores-Staino C., Darai-Ramqvist E., Dobra K., and Hjerpe A. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions Lung Cancer 68 1 2010 39 43
10. Fritcher E.G., Kipp B.R., and Halling K.C. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures Gastroenterology 136 7 2009 2180 2186
11. Reid-Nicholson M.D., Ramalingam P., Adeagbo B., Cheng N., Peiper S.C., and Terris M.K. The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder Mod Pathol 22 1 2009 119 127
12. Yoder B.J., Skacel M., and Hedgepeth R. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings Am J Clin Pathol 127 2 2007 295 301
13. Mayer W.A., Resnick M.J., and Canter D. Synchronous metastatic renal cell carcinoma to the genitourinary tract: two rare case reports and a review of the literature Can J Urol 16 2 2009 4611 4614
14. Sim S.J., Ro J.Y., Ordonez N.G., Park Y.W., Kee K.H., and Ayala A.G. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study Mod Pathol 12 4 1999 351 355
15. Foot N.C., Papanicolaou G.N., Holmquist N.D., and Seybolt J.F. Exfoliative cytology of urinary sediments; a review of 2,829 cases Cancer 11 1 1958 127 137
16. Hajdu S.I., Savino A., Hajdu E.O., and Koss L.G. Cytologic diagnosis of renal cell carcinoma with the aid of fat stain Acta Cytol 15 1 1971 31 33
17. Kawakami H., Hoshida Y., and Hanai J. Voided urine cytology of papillary renal cell carcinoma and renal calculus: report of a case with emphasis on the importance of cytologic screening in high-risk individuals Acta Cytol 45 5 2001 771 774
18. Piscioli F., Detassis C., Polla E., Pusiol T., Reich A., and Luciani L. Cytologic presentation of renal adenocarcinoma in urinary sediment Acta Cytol 27 4 1983 383 390
19. Nguyen G.K., and Schumann G.B. Cytopathology of renal collecting duct carcinoma in urine sediment Diagn Cytopathol 16 5 1997 446 449
20. Umiker W. Accuracy of cytologic diagnosis of cancer of the urinary tract Symposium on Diagnostic Accuracy of Cytologic Technics 8 3 1964 186 191
21. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 7 1982 655 663
22. B. Delahunt, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France 27 29
23. Gasser T., Hartmann A., and Schmitz-Drager B.J. Infiltrating urothelial carcinoma J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France 93 109
24. Harrison J.H., Botsford T.W., and Tucker M.R. The use of the smear of the urinary sediment in the diagnosis and management of neoplasm of the kidney and bladder Surg Gynecol Obstet 92 2 1951 129 139
25. Bonsib S.M., and Moch H. Clear cell renal cell carcinoma J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization Classification of tumours. Pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France 23 25
26. Fuzesi L., Cober M., and Mittermayer C. Collecting duct carcinoma: cytogenetic characterization Histopathology 21 2 1992 155 160
27. van den Berg E. Chromophobe renal cell carcinoma J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization classification of tumours. pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France 30 32
28. Kovacs G., Fuzesi L., Emanual A., and Kung H.F. Cytogenetics of papillary renal cell tumors Genes Chromosomes Cancer 3 4 1991 249 255
29. Eble J.N.T.K., and Pisani P. Renal cell carcinoma J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France
30. http://www.cancernet.gov/cancertopics/types/kidney.
31. Skinner D.G., Colvin R.B., Vermillion C.D., Pfister R.C., and Leadbetter W.F. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases Cancer 28 5 1971 1165 1177
32. Klatte T., Rao P.N., and de Martino M. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma J Clin Oncol 27 5 2009 746 753
33. Klatte T., Pantuck A.J., and Said J.W. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma Clin Cancer Res 15 4 2009 1162 1169
34. Moch H. Oncocytoma J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital system 1st ed. 2004 IARC Press Lyon, France 42 43